Acute lymphoblastic leukaemia - second line - dasatinib initial PBS authority application form (PB077)

Use this form to apply for initial PBS-subsidised dasatinib for second line treatment of acute lymphoblastic leukaemia.

Page last updated: 17 November 2022.
QC 20771